Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial

Yoshinobu Hata,Takaharu Kiribayashi,Kazuma Kishi,Makoto Nagashima,Takefumi Nakayama,Shingo Ikeda,Mitsutaka Kadokura,Yuichi Ozeki,Hajime Otsuka,Yoshitaka Murakami,Keigo Takagi,Akira Iyoda

Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial

2017

Yoshinobu Hata
Takaharu Kiribayashi
Kazuma Kishi
Makoto Nagashima
Takefumi Nakayama
Shingo Ikeda
Mitsutaka Kadokura
Yuichi Ozeki
Hajime Otsuka
Yoshitaka Murakami
Keigo Takagi
Akira Iyoda

Background We conducted a multicenter randomized study of adjuvant S-1 administration schedules for surgically treated pathological stage IB-IIIA non-small cell lung cancer patients.

Keywords:

Randomized controlled trial
Pathology
Medicine
Surgical oncology
Adjuvant
Lung cancer
Chemotherapy
Toxicity
Survival rate
Adverse effect
Alanine transaminase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations